Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.
about
ALK Signaling and Target Therapy in Anaplastic Large Cell LymphomaMolecular characterization of WDCP, a novel fusion partner for the anaplastic lymphoma tyrosine kinase ALKMolecular biology of lung cancerTargeted therapies and immunotherapy in non-small-cell lung cancerTyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical ImplicationsNot all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategyRecent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLCMolecular Subtypes and Personalized Therapy in Metastatic Colorectal CancerGene aberrations for precision medicine against lung adenocarcinomaPatterns of Chromosomal Aberrations in Solid TumorsDifferences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese populationTargeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what's new and what's enoughMET inhibitors in combination with other therapies in non-small cell lung cancerConcise review: The Piwi-piRNA axis: pivotal beyond transposon silencingGenomic profiling of small-cell lung cancer: the era of targeted therapiesFrom human genome to cancer genome: the first decadeMolecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for MolecularAdult lung stem cells and their contribution to lung tumourigenesisBeyond ALK-RET, ROS1 and other oncogene fusions in lung cancerThe minority report: targeting the rare oncogenes in NSCLCSEER cancer registry biospecimen research: yesterday and tomorrowClinical tumor sequencing: opportunities and challenges for precision cancer medicineAdvances of molecular subtype and targeted therapy of lung cancerCrystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617FOncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers.BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibitionWhole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusionsActivity of second-generation ALK inhibitors against crizotinib-resistant mutants in an NPM-ALK model compared to EML4-ALK.Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients.NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer.The possibility of clinical sequencing in the management of cancerTargeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALKGenomic profiling toward precision medicine in non-small cell lung cancer: getting beyond EGFRInhibitors of the anaplastic lymphoma kinaseEpidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC)Characteristics of lung cancers harboring NRAS mutationsIdentification of selective inhibitors of RET and comparison with current clinical candidates through development and validation of a robust screening cascade.
P2860
Q21129306-B46E147E-3E84-4E41-A99F-7AE777217E76Q24308008-DE742F33-38D0-474B-A318-1F831842C87BQ24606677-92A0757D-6615-4B81-9F99-B81D4B4FB90DQ26738986-E2D9E1B8-FF75-4E99-88FF-308870086A32Q26741318-FA967F7E-C708-4CC9-8DB6-9B6946EC9DAAQ26744284-6C03D05D-9706-4766-B92B-4F3CA863E78BQ26747276-8D68B981-9567-4F7F-85F3-5AAE24E4A845Q26747329-3CAA04E4-6F1B-4E67-ABC6-17B1C260EA42Q26749348-383E1DC2-3A0E-4579-A9D5-299A37002982Q26786127-1AF34428-4C29-42E3-8763-4C976591750AQ26786594-F885B09A-E283-49A0-9C74-AFFEC2B8D998Q26799467-4BF248B9-C461-40D0-BE51-F1F803B39DEEQ26823203-B90269B5-7FB7-4892-8C3C-7518F68D1890Q26824060-446D18DC-DA2F-42A5-82D1-1DFDAD362272Q26826915-EFA4E9D9-C4DF-45F2-A6C5-987144682939Q26827640-BD6B187A-7481-4CC0-8493-26C40324BFECQ26828860-18605AA5-AC5D-4F22-A98E-F8A53B1AF51BQ26830034-9AA499E1-CC37-4A77-801A-730689D7C72DQ26851421-84AFA55E-5B02-4542-90ED-C68E7EF82D1EQ26851636-AC91678F-3ADB-49B7-986B-0841C0789125Q26998744-E6CC92D9-811F-4AC7-BE5D-16501E9692B8Q27027942-AF8A496B-723A-4488-9B30-9F1F6FE1D3DAQ27030813-FF95D436-0BA8-4546-B767-9021F167B679Q27670859-FB02DF8B-B129-4B90-AAAB-549264E373EEQ27852601-7F32C4B4-C676-4443-9BDD-3CDB00EFBCADQ27852637-06F3587E-9E41-40C1-9345-C9BA59F551DFQ27852699-52302BAE-CDDF-4936-8855-DF4372B53780Q27852730-A94E1B80-CE39-467A-B5C4-BFCEA855A984Q27853005-9279FE69-07DD-45C1-B4EA-1598138BEE75Q27853012-825115B6-BA9D-4D85-A08A-FC97EF09BC2DQ27853136-6761095B-649F-4F06-9A98-60BF11EADC65Q27853234-2B1613C1-B3A5-4E55-9F95-19DDEDF7257AQ27853306-20D3A5E2-B8A0-4B4C-84CB-F0D27AB6ABD1Q28072144-B381D04C-EBAB-424F-95F2-820CF33488ABQ28083446-F2B373E3-E4FB-4221-9624-A49E77A71CEEQ28086993-1B8CF7D4-58CA-4FE0-973D-E963E6A24F46Q28267124-B02BE114-3B70-47C4-8376-4A1658EE9631Q28284519-408D8938-522F-451A-82CE-6FF915A8D21DQ28706226-80D46559-CFB1-4684-A465-D04D687E6BAAQ28830947-B1BD402C-DC80-462A-A240-A76077B5A79D
P2860
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.
@en
type
label
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.
@en
prefLabel
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.
@en
P2093
P2860
P356
P1433
P1476
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.
@en
P2093
Alex Parker
Amy Donahue
Christine E Sheehan
Dalia Ercan
Doron Lipson
Emily White
Frank Juhn
Garrett M Frampton
Geoff Otto
Hidefumi Sasaki
P2860
P2888
P304
P356
10.1038/NM.2673
P407
P50
P577
2012-02-12T00:00:00Z